Test quickly measures efficacy of Alzheimer's drugs

04/13/2009 | Belleville News-Democrat (Ill.)

Researchers said a new called stable isotope-lined kinetics can assess the efficacy of a drug for Alzheimer's disease in only 36 hours. The test was used to show that an Eli Lilly and Co. drug, which is in late-stage trials, reduced the production of amyloid beta. The test might also be used toward hastening the development of Alzheimer's drugs, the researchers said.

View Full Article in:

Belleville News-Democrat (Ill.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID